Thomas P. O’Neill
President & CEO
Thomas P. O’Neill joined Cognivue® in April, 2018 as President and CEO. Mr. O’Neill has more than 25 years of experience leading commercial operations and a proven track record in growing revenue and EBITDA while driving operational excellence and improving customer satisfaction. Prior to joining Cognivue, Mr. O’Neill served as President, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences where he helped set the stage for long-term sustainable growth.
Prior to Qiagen, he served as the President for Hologic’s GYN, Surgical Solutions business, where he led the turnaround and significant top and bottom line growth for the Division. From 2013 to 2015, Mr. O’Neill was the President for North American Commercial Operations for Ortho Clinical Diagnostics, where he was responsible for $850 million in revenue and oversaw more than 600 professionals across all commercial functions. Under his leadership, Ortho Clinical exceeded all financial targets and restored growth to the North American business. From 2009 to 2013, Mr. O’Neill held positions of increasing responsibility at Bausch + Lomb Incorporated, most recently as Vice President and General Manager, North American Vision Care.
Prior to Bausch + Lomb, Mr. O’Neill held leadership positions at SynergEyes and Valeant Pharmaceuticals. From 1994 to 2005, he held sales and marketing positions within the Johnson and Johnson Family of Companies including Ortho-McNeil Pharmaceuticals, McNeil Consumer Healthcare and J&J/Merck. Mr. O’Neill received a B.S. in Business Administration and Marketing from the University of Akron.
Reina Benabou MD PhD
SVP & Chief Medical Officer
Reina Benabou, MD, PhD joined Cognivue® in October 2018 as Senior Vice President and Chief Medical Officer. Dr. Benabou is an accomplished global clinical development and medical affairs pharmaceutical executive who is passionate about innovating in Neurosciences and creating value to make a difference in patients’ lives.
Including academic appointments at the Neurology Departments of Mount Sinai School of Medicine and Columbia University in New York, she has over 20 years of experience in clinical development and medical affairs, with a significant number of Neuroscience related peer reviewed papers published in medical journals.
Dr. Benabou started her Pharma Industry career at Schering Plough in 2003 leading several CNS projects. Later, she joined Pfizer in 2006 and the US Lyrica team during its product launch. From then on, she was assigned various positions of increased responsibility within development and medical organizations such as Head of Medical Affairs within Emerging Markets and Head of Global Medical Product Evaluation. During this time, she worked in close collaboration with safety & regulatory. In 2014, she joined Novartis in Basel, Switzerland as VP & World Wide Medical Head for the Neuroscience Franchise and acting Global Medical Communication and Information Head. Most recently, she worked at AstraZeneca as US Medical Affairs VP. Through these years, Dr. Benabou established herself as a strategically-minded leader. She demonstrated her ability to guide impactful evidence generation that translated into impactful clinical benefits for patients and for all key stakeholders in the healthcare ecosystem. With that, she spearheaded development and medical affairs strategies leading to successful product approvals & launches that also optimized patient access across Neurosciences & other TAs within different geographies and business models. Through it all, she has a track record of building and leading a variety of US and global high performing in-house & field medical teams that delivered exceptional results even in challenging situations, upholding the highest ethical & compliance standards
During her career, Dr. Benabou has been granted several awards embodying patient focus, cross-functional collaboration, high business impact and exemplary leadership. She has a MD from Sao Paulo, Brazil; Neurology training, fellowships and a PhD in Neurological Sciences completed respectively at McGill University and University of Montreal, Canada.
Vice President of Sales
Whitney Parachek joined Cognivue in August 2018 as Vice President of Sales. Ms. Parachek brings more than 20 years of commercial experience leading and developing high performance teams in the healthcare and device sector.
With a commitment to long term growth, she focuses on performance through the recruitment, development and engagement of high level talent. From 1999 – 2007 Ms. Parachek worked at CYTYC Corporation in various roles of increasing responsibility. In 2008 she joined the Hologic leadership team as part of the Cytyc acquisition. In 2014 she was promoted to Vice President of Sales for the Gynecologic Surgical Division and was tasked with the responsibility of turning around a declining business. During her three year tenure as VP of Sales, she was successful leading over 250 employees to drive double digit growth in a $400M business. In 2017 Whitney was promoted to Vice President Commercial Engagement responsible for ensuring the successful execution of long term strategic plans, engagement, and alignment of business unit integration.
She is driven by her passion to improve the lives of patients through innovative technologies, superior service, and valuable business solutions. Ms. Parachek earned a B.S. in Kinesiology from the College of Charleston in Charleston, South Carolina.
Paul W. Estes
Vice President of Operations
Beginning in 2009, Paul Estes helped conceive and develop Cognivue® technology, playing integral roles in de novo 510(k) clearance from the U.S. Food and Drug Administration and its commercialization.
Today, as Director of Operations and a member of the company’s leadership team, he collaborates on planning for technology roadmaps, new product development and expansion, business relations, sales team integration, and staffing. He also holds responsibility for intellectual property management, quality and regulatory affairs, manufacturing, software development, and customer training and support.
Paul has a B.S. degree in Education from Houghton College.
Vice President of National Accounts
Jeff Keys joined Cognivue® in April 2018 as Vice President of National Accounts and is a member of the leadership team. With nearly 15 years in medical device executive and sales roles, he has grown revenues and built high performing teams by focusing on the customer experience.
At Cognivue, Jeff is collaborating with integrated delivery networks and hospital groups to gain market adoption for the company’s innovative system. He is also working closely with clinical account managers on training and sales implementation to drive market penetration and growth.
Jeff previously served as area Sales Manager for Invuity, a leader in surgical photonics, and with Intuitive Surgical, where he was instrumental in growing the adoption of robotic surgery. He also held roles with Medical Action Industries, leading an eight-state sales team. Jeff holds a B.S. in Business Administration from Nazareth College.